• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经典和替代途径调节活性在衰变加速因子中的定位。

Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.

作者信息

Brodbeck W G, Liu D, Sperry J, Mold C, Medof M E

机构信息

Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

J Immunol. 1996 Apr 1;156(7):2528-33.

PMID:8786315
Abstract

Decay-accelerating factor (DAF) is a cell-associated C regulatory protein that protects host cells from autologous C attack. It functions intrinsically in host cell surface membranes to rapidly dissociate autologous classical and alternative pathway C3 convertases whenever these amplifying enzymes assemble on host cell surfaces. It is composed of four contiguous approximately 70 amino acid long regions termed short consensus repeats (SCRs) that share homology with similar units in other C3 convertase regulatory proteins. It is attached to the cell surface membrane by a glycoinositol phospholipid (GPI) anchor that is added posttranslationally. In this study, we prepared rGPI-anchored DAF proteins devoid of individual SCRs. We then incorporated the GPI-anchored products into sheep erythrocyte (Esh) hemolytic intermediates and examined their abilities to intrinsically regulate classical or alternative pathway activation. We found that classical pathway C3 convertase regulatory function resides within SCR-2 and SCR-3, while alternative pathway C3 convertase regulatory function resides within SCR-2, -3, and -4. Functional comparisons of the variant DAF proteins in fluid phase C3 activation assays established that the differences reflect domain-specific interactions rather than changes in the spatial arrangement of SCRs above the cell surface. In accordance with these findings, we found that variant DAF molecules containing SCR-1, -2, and -3, but not SCR-4, function to selectively inhibit classical pathway activation.

摘要

衰变加速因子(DAF)是一种细胞相关的补体调节蛋白,可保护宿主细胞免受自身补体攻击。它在宿主细胞表面膜中发挥内在作用,每当这些放大酶在宿主细胞表面组装时,能迅速解离自身经典和替代途径的C3转化酶。它由四个连续的、长度约为70个氨基酸的区域组成,称为短共识重复序列(SCR),与其他C3转化酶调节蛋白中的类似单元具有同源性。它通过翻译后添加的糖基磷脂酰肌醇(GPI)锚定在细胞表面膜上。在本研究中,我们制备了不含单个SCR的重组GPI锚定DAF蛋白。然后将GPI锚定产物掺入绵羊红细胞(Esh)溶血中间体中,并检测它们内在调节经典或替代途径激活的能力。我们发现经典途径C3转化酶调节功能存在于SCR-2和SCR-3中,而替代途径C3转化酶调节功能存在于SCR-2、-3和-4中。在液相C3激活试验中对变异DAF蛋白的功能比较表明,这些差异反映了结构域特异性相互作用,而非细胞表面以上SCR空间排列的变化。根据这些发现,我们发现含有SCR-1、-2和-3但不含SCR-4的变异DAF分子可选择性抑制经典途径激活。

相似文献

1
Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.经典和替代途径调节活性在衰变加速因子中的定位。
J Immunol. 1996 Apr 1;156(7):2528-33.
2
Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.衰变加速因子在存在C4或C3肾炎因子的情况下对经典途径和替代途径C3转化酶组装的影响。
Immunology. 1989 Dec;68(4):449-52.
3
Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.一种杂交补体调节蛋白——中国仓鼠卵巢细胞膜辅因子蛋白衰变加速因子的表达。其调节作用与衰变加速因子和膜辅因子蛋白调节作用的比较。
J Immunol. 1994 Apr 1;152(7):3436-44.
4
The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.膜成分对衰变加速因子调节替代途径激活的影响。
J Immunol. 1990 Dec 1;145(11):3836-41.
5
Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.对补体替代途径激活对衰变加速因子单独缺乏的红细胞的影响的分析。
J Immunol. 1992 Jan 15;148(2):498-502.
6
Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.加速人C3转化酶衰变的小鼠补体膜抑制剂。
Immunology. 1989 Dec;68(4):439-44.
7
Functional differences among multiple isoforms of guinea pig decay-accelerating factor.豚鼠衰变加速因子多种同工型之间的功能差异。
J Immunol. 1998 Mar 15;160(6):3014-22.
8
Structure/function studies of human decay-accelerating factor.人类衰变加速因子的结构/功能研究
Immunology. 2000 Sep;101(1):104-11. doi: 10.1046/j.1365-2567.2000.00086.x.
9
Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.人衰变加速因子中表位、糖基化位点及补体调节结构域的图谱分析
J Immunol. 1992 Nov 1;149(9):2906-13.
10
Purification and characterization of decay-accelerating factor (DAF) from Raji cells.从Raji细胞中纯化和鉴定衰变加速因子(DAF)
Immunology. 1988 Jul;64(3):369-74.

引用本文的文献

1
Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathways.三融合蛋白(TriFu):一种对所有三种补体激活途径均有效的、靶向性的、类似酶的抑制剂。
J Biol Chem. 2024 Apr;300(4):105784. doi: 10.1016/j.jbc.2024.105784. Epub 2024 Feb 23.
2
Baculovirus expression systems for production of recombinant proteins in insect and mammalian cells.用于在昆虫和哺乳动物细胞中生产重组蛋白的杆状病毒表达系统。
Mol Biol. 2011;45(1):123-138. doi: 10.1134/S002689331101002X. Epub 2011 Feb 22.
3
Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade.
将 MAP-1:CD35 或 MAP-1:CD55 融合蛋白与模式识别分子相结合,作为补体级联的新型靶向调节剂。
FASEB J. 2019 Nov;33(11):12723-12734. doi: 10.1096/fj.201901643R. Epub 2019 Aug 30.
4
Molecular engineering of an efficient four-domain DAF-MCP chimera reveals the presence of functional modularity in RCA proteins.高效四域 DAF-MCP 嵌合体的分子工程揭示 RCA 蛋白中存在功能模块化。
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9953-9958. doi: 10.1073/pnas.1818573116. Epub 2019 Apr 29.
5
Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.补体治疗与纳米医学相遇:用 CD55 的可溶性结构域克服纳米药物的人补体激活和白细胞摄取。
J Control Release. 2019 May 28;302:181-189. doi: 10.1016/j.jconrel.2019.04.009. Epub 2019 Apr 8.
6
Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine.补体系统与年龄相关性黄斑变性:基因-环境相互作用对预防医学和个体化医学的影响。
Biomed Res Int. 2018 Aug 26;2018:7532507. doi: 10.1155/2018/7532507. eCollection 2018.
7
DAF in diabetic patients is subject to glycation/inactivation at its active site residues.糖尿病患者体内的脱辅基脂蛋白因子(DAF)在其活性位点残基处会发生糖基化/失活。
Mol Immunol. 2018 Jan;93:246-252. doi: 10.1016/j.molimm.2017.06.036. Epub 2017 Sep 5.
8
Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion.劫持补体调节蛋白以实现细菌免疫逃逸。
Front Microbiol. 2016 Dec 20;7:2004. doi: 10.3389/fmicb.2016.02004. eCollection 2016.
9
The immunohistochemical analysis of membrane-bound CD55, CD59 and fluid-phase FH and FH-like complement inhibitors in cancers of ovary and corpus uteri origin.卵巢和子宫起源癌症中膜结合型CD55、CD59以及液相FH和FH样补体抑制剂的免疫组化分析
Cent Eur J Immunol. 2015;40(3):349-53. doi: 10.5114/ceji.2015.54598. Epub 2015 Oct 15.
10
Investigating the structure of the factor B vWF-A domain/CD55 protein-protein complex using DEER spectroscopy: successes and pitfalls.使用双电子-电子共振光谱研究因子B血管性血友病因子A结构域/CD55蛋白-蛋白复合物的结构:成功与陷阱
Mol Phys. 2013 Oct;111(18-19):2865-2872. doi: 10.1080/00268976.2013.827754. Epub 2013 Oct 9.